Attenuation Correction Method Research Articles

Impact of non-uniform attenuation correction in a dynamic [18F]-FDOPA brain PET/MRI study

BackgroundPET (positron emission tomography) biokinetic modelling relies on accurate quantitative data. One of the main corrections required in PET imaging to obtain high quantitative accuracy is tissue attenuation correction (AC). Incorrect non-uniform PET-AC may result in local bias in the emission images, and thus in relative activity distributions and time activity curves for different regions. MRI (magnetic resonance imaging)-based AC is an active area of research in PET/MRI neuroimaging, where several groups developed in the last few years different methods to calculate accurate attenuation (μ-)maps. Some AC methods have been evaluated for different PET radioisotopes and pathologies. However, AC in PET/MRI has scantly been investigated in dynamic PET studies where the aim is to get quantitative kinetic parameters, rather than semi-quantitative parameters from static PET studies. In this work, we investigated the impact of AC accuracy in PET image absolute quantification and, more importantly, in the slope of the Patlak analysis based on the simplified reference tissue model, from a dynamic [18F]-fluorodopa (FDOPA) PET/MRI study. In the study, we considered the two AC methods provided by the vendor and an in-house AC method based on the dual ultrashort time echo MRI sequence, using as reference a multi-atlas-based AC method based on a T1-weighted MRI sequence.ResultsNon-uniform bias in absolute PET quantification across the brain, from − 20% near the skull to − 10% in the central region, was observed using the two vendor’s μ-maps. The AC method developed in-house showed a − 5% and 1% bias, respectively. Our study resulted in a 5–9% overestimation of the PET kinetic parameters with the vendor-provided μ-maps, while our in-house-developed AC method showed < 2% overestimation compared to the atlas-based AC method, using the cerebellar cortex as reference region. The overestimation obtained using the occipital pole as reference region resulted in a 7–10% with the vendor-provided μ-maps, while our in-house-developed AC method showed < 6% overestimation.ConclusionsPET kinetic analyses based on a reference region are especially sensitive to the non-uniform bias in PET quantification from AC inaccuracies in brain PET/MRI. Depending on the position of the reference region and the bias with respect to the analysed region, kinetic analyses suffer different levels of bias. Considering bone in the μ-map can potentially result in larger errors, compared to the absence of bone, when non-uniformities in PET quantification are introduced.

Attenuation correction of a flat table top for radiation therapy in hybrid PET/MR using CT- and 68Ge/68Ga transmission scan-based μ-maps

Hybrid PET/MR offers new opportunities in radiation oncology for tissue/tumour characterisation and response assessment. Attenuation correction (AC) is an important issue especially in the presence of immobilization devices and flat table tops (FTT). The goal of this study was to compare two methods of AC using CT- and 68Ge/68Ga transmission scan-based attenuation maps (μ-maps) for a custom-designed FTT. Measurements were performed in the mMR PET/MR and TrueV PET/CT Biograph Siemens scanners with three different phantoms, namely the Siemens MR-QA, a cubic canister and the NEMA IEC body phantom. The study revealed that the MR image quality is not hampered by the presence of the FTT. For cubic canister applying the scanner’s inherent AC alone resulted in inaccuracies in PET images, with up to −4.0% underestimation of the activity. The mean NEMA sphere activity measurements without FTT, agreed within 3.5% with the respective inserted activity. Placing the FTT in the PET/MR scanner resulted in a difference to the injected activity of 4.5% when the table was not corrected for. By introducing the μ-maps the discrepancy between the used activity and the measurements decreased down to 2.6%. To improve the AC of the FTT the creation of a dedicated μ-map was necessary while the CT-based μ-map performed equally good as the source transmission scan-based one.

An Aristotelian View on MR-Based Attenuation Correction (ARISTOMRAC): Combining the Four Elements

MR-based attenuation correction (MRAC) is important for accurate quantification of the uptake of PET tracers in combined PET/MR scanners. However, current techniques for MRAC usually require multiple acquisitions or complex post-processing to discriminate the different tissues. Inspired by the ancient Greeks, who believed that matter was made of the combination of four elements (earth, water, air and fire), we formulated a multi-component Magnetic Resonance (MR) Fingerprinting framework, where every voxel was considered a weighted combination of four base elements: bone, water, air and fat. We named our approach Aristotelian MR based attenuation correction (ARISTOMRAC). We used a 3D radial acquisition scheme at 1.5T, acquiring a transient-state spoiled acquisition with variable flip angles and echo times (TE), with the shortest TEs being ultra-short echo times (UTE). We simulated a multi-tissue MR signal model using the Bloch equations and used dictionary matching to extract tissue fraction maps for bone water and fat, while air fractions were obtained by thresholding the UTE parts of our acquisitions at higher spatial resolution. Compared to previous methods for MR-based Attenuation Correction (MRAC), our approach used a full multi-component signal model, including multiple tissues per voxel. For this reason, rather than reconstructing high resolutions images, MR data can be acquired more efficiently, directly at the resolution needed for PET attenuation maps. The ARISTOMRAC method allows to accurately estimate the air, water, bone and fat fractions (Concordance Correlation Coefficient = 0.81/0.91/0.98 for bone, water and fat respectively). Attenuation maps could be obtained in the head and neck with a single 1-minute acquisition.

Quantitative Imaging of Gd Nanoparticles in Mice Using Benchtop Cone-Beam X-ray Fluorescence Computed Tomography System.

Nanoparticles (NPs) are currently under intensive research for their application in tumor diagnosis and therapy. X-ray fluorescence computed tomography (XFCT) is considered a promising non-invasive imaging technique to obtain the bio-distribution of nanoparticles which include high-Z elements (e.g., gadolinium (Gd) or gold (Au)). In the present work, a set of experiments with quantitative imaging of GdNPs in mice were performed using our benchtop XFCT device. GdNPs solution which consists of 20 mg/mL NaGdF4 was injected into a nude mouse and two tumor-bearing mice. Each mouse was then irradiated by a cone-beam X-ray source produced by a conventional X-ray tube and a linear-array photon counting detector with a single pinhole collimator was placed on one side of the beamline to record the intensity and spatial information of the X-ray fluorescent photons. The maximum likelihood iterative algorithm with scatter correction and attenuation correction method was applied for quantitative reconstruction of the XFCT images. The results show that the distribution of GdNPs in each target slice (containing liver, kidney or tumor) was well reconstructed and the concentration of GdNPs deposited in each organ was quantitatively estimated, which indicates that this benchtop XFCT system provides convenient tools for obtaining accurate concentration distribution of NPs injected into animals and has potential for imaging of nanoparticles in vivo.

A Quantitative Evaluation of Joint Activity and Attenuation Reconstruction in TOF PET/MR Brain Imaging.

Time-of-flight (TOF) PET data provide an effective means for attenuation correction (AC) when no (or incomplete or inaccurate) attenuation information is available. Since MR scanners provide little information on photon attenuation of different tissue types, AC in hybrid PET/MR scanners has always been challenging. In this contribution, we aim at validating the activity reconstructions of the maximum-likelihood ordered-subsets activity and attenuation (OSAA) reconstruction algorithm on a patient brain data set. We present a quantitative comparison of joint reconstructions with the current clinical gold standard-ordered-subsets expectation maximization-using CT-based AC in PET/CT, as well as the current state of the art in PET/MR, that is, zero time echo (ZTE)-based AC. Methods: The TOF PET emission data were initially used in a preprocessing stage to estimate crystal maps of efficiencies, timing offsets, and timing resolutions. Applying these additional corrections during reconstructions, OSAA, ZTE-based, and the vendor-provided atlas-based AC techniques were analyzed and compared with CT-based AC. In our initial study, we used the CT-based estimate of the expected scatter and later used the ZTE-based and OSAA attenuation estimates to compute the expected scatter contribution of the data during reconstructions. In all reconstructions, a maximum-likelihood scaling of the single-scatter simulation estimate to the emission data was used for scatter correction. The reconstruction results were analyzed in the 86 segmented regions of interest of the Hammers atlas. Results: Our quantitative analysis showed that, in practice, a tracer activity difference of +0.5% (±2.1%) and +0.1% (±2.3%) could be expected for the state-of-the-art ZTE-based and OSAA AC methods, respectively, in PET/MR compared with the clinical gold standard in PET/CT. Conclusion: Joint activity and attenuation estimation methods can provide an effective solution to the challenging AC problem for brain studies in hybrid TOF PET/MR scanners. With an accurate TOF-based (timing offsets and timing resolutions) calibration, and similar to the results of the state-of-the-art method in PET/MR, regional errors of joint TOF PET reconstructions are within a few percentage points.

An improved self-consistent approach to attenuation correction for C-band polarimetric radar measurements and its impact on quantitative precipitation estimation

Attenuation correction of measured reflectivity (ZH) and differential reflectivity (ZDR) is critical in short-wavelength radar applications, especially during extreme precipitation events such as heavy rain. This paper develops an improved self-consistent approach (improved ZPHI method) for attenuation correction in practical environment. In particular, a non-negative constraint is imposed on the specific attenuation, which is inferred from the monotonic increasing characteristic of differential propagation phase (ΦDP). The copolar correlation coefficient (ρHV) is used to partition the ΦDP profiles into independent range segments, which are featured by different hydrometeor phases such as liquid rain or mixed-phase precipitation. Additional minimization constraint is imposed on the cost function of the difference between preprocessed ΦDP and reconstructed ΦDPto ensure its appropriate convergence. In addition, an exponential ZDR − ZH relation derived from local raindrop size distribution (DSD) data is applied in the procedure of ZDR correction. Polarimetric measurements from a C-band radar (CPOL) in Hangzhou of China during two extreme precipitation events are used to demonstrate the improved attenuation correction method. DSD observations from disdrometers and radar data from a nearby system operating at non-attenuated frequency (i.e., S-band) at Huangshan Mountain are used to evaluate the attenuation correction performance. This paper also studies the impact of attenuation correction on the radar-derived quantitative precipitation estimation (QPE) product, through cross-comparison with rain gauge observations. Results show that the polarimetric observations from CPOL radar are effectively enhanced and more consistent with collocated S-band measurements and the simulated radar moments based on DSD data. Hourly rainfall products derived from R(ZH) and R(ZH,ZDR) are significantly improved, which are comparable to R(KDP) after attenuation correction.

Bone SPECT-based segmented attenuation correction for quantitative analysis of bone metastasis (B-SAC): comparison with CT-based attenuation correction

BackgroundEvidence has shown the clinical usefulness of measuring the metastatic tumor burden of bone for prognostic assessment especially in prostate cancer; quantitative evaluation by dedicated SPECT is difficult due to the lack of attenuation correction (AC) method.We developed a novel method for attenuation correction using bone SPECT emission data (bone SPECT-based segmented attenuation correction; B-SAC) where emission data were virtually segmented into three tissues (i.e., bone, soft tissue, and air). Then, the pixel values in SPECT were replaced by 50 for the virtual soft tissue, and − 1000 for the virtual air. The replaced pixel values for the virtual bone were based on the averaged CT values of the normal vertebrae (B-SACN) or the metastatic bones (B-SACM). Subsequently, the processed SPECT data (i.e., SPECT value) were supposed to realize CT data (i.e., CT value) that were used for B-SAC. The standardized uptake values (SUVs) of 112 metastatic bone tumors in 15 patients with prostate cancer were compared between CTAC with scatter correction (SC) and resolution recovery (RR) and the following reconstruction conditions: B-SACN (+)SC(+)RR(+), B-SACM (+)SC(+)RR(+), uniform AC(UAC)(+)SC(+)RR(+), AC(−)SC(+)RR(+), and no correction (NC).ResultsThe SUVs in the five reconstruction conditions were all correlated with those in CTAC(+)SC(+)RR(+) (p < 0.01), and the correlations between B-SACN or B-SACM and CTAC images were excellent (r > 0.94). Bland-Altman analysis showed that the mean SUV differences between CTAC (+)SC(+)RR(+) and the other five reconstructions were 0.85 ± 2.25 for B-SACN (+)SC(+)RR(+), 1.61 ± 2.36 for B-SACM (+)SC(+)RR(+), 1.54 ± 3.84 for UAC(+)SC(+)RR(+), − 3.12 ± 4.97 for AC(−)SC(+)RR(+), and − 5.96 ± 4.59 for NC. Compared to CTAC(+)SC(+)RR(+), B-SACN (+)SC(+)RR(+) showed a slight but constant overestimation (approximately 17%) of the metastatic tumor burden of bone when the same threshold of metabolic tumor volume was used.ConclusionsThe results of this preliminary study suggest the potential for B-SAC to improve the quantitation of bone metastases in bone SPECT when X-ray CT or transmission CT data are not available. Considering the small but unignorable differences of lesional SUVs between CTAC and B-SAC, SUVs obtained with the current version of B-SAC seem difficult to be directly compared with those obtained with CTAC.

No need for frame-wise attenuation correction in dynamic Rubidium-82 PET for myocardial blood flow quantification

BackgroundRegadenoson-induced stress causes a repositioning of the heart, myocardial creep, in half of the patients undergoing Rubidium-82 (Rb-82) positron emission tomography (PET). As a result, misalignment of dynamic PET and computer tomography (CT) may occur, possibly affecting CT-based attenuation correction (AC) and thereby PET-based myocardial blood flow (MBF) quantification. Our aim was to determine the need for frame-wise PET-CT AC to obtain reliable MBF measurements. Methods31 Out of 64 consecutive patients had myocardial creep during regadenoson-induced stress Rb-82 PET-CT and were included. Prior to PET image reconstruction, we applied two AC methods; single PET-CT alignment and frame-wise alignment in which PET time-frames with myocardial creep were individually co-registered with CT. The PET-CT misalignment was then quantified and MBFs for the three vascular territories and whole myocardium were calculated and compared between both methods. ResultsThe magnitude of misalignment due to myocardial creep was 13.8 ± 4.5 mm in caudal-cranial direction, 1.8 ± 2.1 mm in medial-lateral and 2.5 ± 1.8 mm in anterior-posterior direction. Frame-wise PET-CT registration did not result in different MBF measurements (P ≥ .07) and the magnitude of misalignment and MBF differences did not correlate (P ≥ .58). ConclusionThere is no need for frame-wise AC in dynamic Rb-82 PET for MBF quantification. Single alignment seems sufficient in patients with myocardial creep.

Assessment of Left Ventricular Ejection Fraction by Thallium-201 Myocardial SPECT-CT in Patients with Angina Pectoris: Comparison with 2D Echocardiography.

Left ventricular (LV) ejection fraction (EF) is an important parameter for assessing cardiac systolic function and predicting prognosis in patients with cardiovascular disease. The aim of this study was to evaluate the feasibility of assessing LVEF by Tl-201 hybrid myocardial single-photon emission computed tomography (SPECT)/CT using two attenuation correction methods in patients with angina pectoris. A total of 339 patients with angina pectoris (62.8 ± 12.9years, male:female = 206:133) were analyzed. All patients underwent Tl-201 myocardial SPECT/CT and transthoracic two-dimensional (2D) echocardiograph. We compared LVEF assessed by SPECT/CT using two attenuation correction methods: CT-based attenuation correction (CTAC) and non-attenuation correction (non-AC) methods and 2D echocardiography. LVEF assessed by either of the two attenuation correction techniques and 2D echocardiography showed moderate correlation in all patients with angina pectoris (r= 0.487 for CTAC and r= 0.473 for non-AC, p <0.001). Results were similar in the subgroup of patients with perfusion abnormalities on myocardial SPECT/CT images. Overall diagnostic performances were similar for the CTAC and non-AC methods for evaluating normal and decreased LVEF by myocardial SPECT/CT. LVEF measured by the CTAC method of Tl-201-gated myocardial SPECT/CT was comparable with the conventional non-AC method in patients with angina pectoris and in the subgroup of patients with perfusion abnormality. Tl-201-gated myocardial hybrid SPECT/CT can be a reliable tool in the assessment of LVEF in clinic.

Dynamic [18F]FET-PET/MRI using standard MRI-based attenuation correction methods

AimTo assess if tumour grading based on dynamic [18F]FET positron emission tomography/magnetic resonance imaging (PET/MRI) studies is affected by different MRI-based attenuation correction (AC) methods.MethodsTwenty-four patients with suspected brain tumours underwent dynamic [18F]FET-PET/MRI examinations and subsequent low-dose computed tomography (CT) scans of the head. The dynamic PET data was reconstructed using the following AC methods: standard Dixon-based AC and ultra-short echo time MRI-based AC (MR-AC) and a model-based AC approach. All data were reconstructed also using CT-based AC (reference). For all lesions and reconstructions, time-activity curves (TACs) and time to peak (TTP) were extracted using different region-of-interest (ROI) and volume-of-interest (VOI) definitions. According to the most common evaluation approaches, TACs were categorised into two or three distinct curve patterns. Changes in TTP and TAC patterns compared to PET using CT-based AC were reported.ResultsIn the majority of cases, TAC patterns did not change. However, TAC pattern changes as well as changes in TTP were observed in up to 8% and 17% of the cases when using different MR-AC methods and ROI/VOI definitions, respectively. However, these changes in TTP and TAC pattern were attributed to different delineations of the ROIs/VOIs in PET corrected with different AC methods.ConclusionPET/MRI using different MR-AC methods can be used for the assessment of TAC patterns in dynamic [18F]FET studies, as long as a meaningful delineation of the area of interest within the tumour is ensured.Key Points• PET/MRI using different MR-AC methods can be used for dynamic [18F]FET studies.• A meaningful segmentation of the area of interest needs to be ensured, mandating a visual validation of the delineation by an experienced reader.

Deep Learning Based Attenuation Correction of PET/MRI in Pediatric Brain Tumor Patients: Evaluation in a Clinical Setting.

Aim: Positron emission tomography (PET) imaging is a useful tool for assisting in correct differentiation of tumor progression from reactive changes. O-(2-18F-fluoroethyl)-L-tyrosine (FET)-PET in combination with MRI can add valuable information for clinical decision making. Acquiring FET-PET/MRI simultaneously allows for a one-stop-shop that limits the need for a second sedation or anesthesia as with PET and MRI in sequence. PET/MRI is challenged by lack of a direct measure of photon attenuation. Accepted solutions for attenuation correction (AC) might not be applicable to pediatrics. The aim of this study was to evaluate the use of the subject-specific MR-derived AC method RESOLUTE, modified to a pediatric cohort, against the performance of an MR-AC technique based on deep learning in a pediatric brain tumor cohort.Methods: The modifications to RESOLUTE and the implementation of a deep learning method were performed using 79 pediatric patient examinations. We analyzed the 36 of these with active brain tumor area above 1 mL. We measured background (B), tumor mean and maximal activity (TMEAN, TMAX), biological tumor volume (BTV), and calculated the clinical metrics TMEAN/B and TMAX/B.Results: Overall, we found both RESOLUTE and our DeepUTE methodologies to accurately reproduce the CT-AC clinical metrics. Regardless of age, both methods were able to obtain AC maps similar to the CT-AC, albeit with DeepUTE producing the most similar based on both quantitative metrics and visual inspection. In the patient-by-patient analysis DeepUTE was the only technique with all patients inside the predefined acceptable clinical limits. It also had a higher precision with relative %-difference to the reference CT-AC (TMAX/B mean: -0.1%, CI: [-0.8%, 0.5%], p = 0.54) compared to RESOLUTE (TMAX/B mean: 0.3%, CI: [-0.6%, 1.2%], p = 0.67) and DIXON-AC (TMAX/B mean: 5.9%, CI: [4.5%, 7.4%], p < 0.0001).Conclusion: Overall, we found DeepUTE to be the AC method that most robustly reproduced the CT-AC clinical metrics per se, closely followed by RESOLUTE modified to pediatric cohorts. The added accuracy due to better noise handling of DeepUTE, ease of use, as well as the improved runtime makes DeepUTE the method of choice for PET/MRI attenuation correction.

Development of an attenuation correction method for direct x-ray fluorescence (XRF) imaging utilizing gold L-shell XRF photons.

This work proposes a semiempirical correction method for attenuation of x-ray fluorescence (XRF) photons and/or an excitation beam during direct XRF imaging (i.e., mapping) of gold nanoparticle (GNP) distribution utilizing gold L-shell XRF photons. The current method was first devised by finding the two following relationships: (a) ratio of gold XRF peak intensity (Lα at ~9.7keV and Lβ at ~11.4keV) vs pathlength of XRF photons; (b) XRF photon counts produced (Nxrf ) vs scattered photon counts produced (Nscat ). Monte Carlo simulations were performed using the Geant4 tool kit to characterize the aforementioned relationships for different tissue-like media. The applicability of the method was tested experimentally by acquiring 2D L-shell XRF images of custom-made phantoms using an experimental benchtop x-ray fluorescence computed tomography setup. The results show that the ratio of gold L-shell XRF peak intensities allowed an estimation of the pathlength of XRF photons, thus can be utilized to correct for attenuation of XRF photons after emission. The results also demonstrate that Nscat , through a proportionality where the exponent T depends on the energy of scattered photons, could be used to correct for attenuation of an excitation beam prior to producing XRF photons. The corrected XRF signal was found independent of the densities of tissue-like media present along the passage of an excitation beam or emitted XRF photons. The current results suggest that the developed attenuation correction method plays an essential role for the detection of GNPs on the order of parts-per-million, and also for the determination of GNP concentration/location within the imaging object made of tissue-like media, without any prior knowledge of the imaging object shape, under the conditions deemed relevant to biomedicalapplications of gold L-shell XRF-based imaging.

Accurate hybrid template\u2013based and MR-based attenuation correction using UTE images for simultaneous PET/MR brain imaging applications

BackgroundAttenuation correction is one of the most crucial correction factors for accurate PET data quantitation in hybrid PET/MR scanners, and computing accurate attenuation coefficient maps from MR brain acquisitions is challenging. Here, we develop a method for accurate bone and air segmentation using MR ultrashort echo time (UTE) images.MethodsMR UTE images from simultaneous MR and PET imaging of five healthy volunteers was used to generate a whole head, bone and air template image for inclusion into an improved MR derived attenuation correction map, and applied to PET image data for quantitative analysis. Bone, air and soft tissue were segmented based on Gaussian Mixture Models with probabilistic tissue maps as a priori information. We present results for two approaches for bone attenuation coefficient assignments: one using a constant attenuation correction value; and another using an estimated continuous attenuation value based on a calibration fit. Quantitative comparisons were performed to evaluate the accuracy of the reconstructed PET images, with respect to a reference image reconstructed with manually segmented attenuation maps.ResultsThe DICE coefficient analysis for the air and bone regions in the images demonstrated improvements compared to the UTE approach, and other state-of-the-art techniques. The most accurate whole brain and regional brain analyses were obtained using constant bone attenuation coefficient values.ConclusionsA novel attenuation correction method for PET data reconstruction is proposed. Analyses show improvements in the quantitative accuracy of the reconstructed PET images compared to other state-of-the-art AC methods for simultaneous PET/MR scanners. Further evaluation is needed with radiopharmaceuticals other than FDG, and in larger cohorts of participants.

Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging\u2014comparison to head atlas and 68Ge-transmission-based attenuation correction

BackgroundMRI does not offer a direct method to obtain attenuation correction maps as its predecessors (stand-alone PET and PET/CT), and bone visualisation is particularly challenging. Recently, zero-echo-time (ZTE) was suggested for MR-based attenuation correction (AC). The aim of this work was to evaluate ZTE- and atlas-AC by comparison to 68Ge-transmission scan-based AC.Nine patients underwent brain PET/MR and stand-alone PET scanning using the dopamine transporter ligand 11C-PE2I. For each of them, two AC maps were obtained from the MR images: an atlas-based, obtained from T1-weighted LAVA-FLEX imaging with cortical bone inserted using a CT-based atlas, and an AC map generated from proton-density-weighted ZTE images. Stand-alone PET 68Ge-transmission AC map was used as gold standard. PET images were reconstructed using the three AC methods and standardised uptake value (SUV) values for the striatal, limbic and cortical regions, as well as the cerebellum (VOIs) were compared. SUV ratio (SUVR) values normalised for the cerebellum were also assessed. Bias, precision and agreement were calculated; statistical significance was evaluated using Wilcoxon matched-pairs signed-rank test.ResultsBoth ZTE- and atlas-AC showed a similar bias of 6–8% in SUV values across the regions. Correlation coefficients with 68Ge-AC were consistently high for ZTE-AC (r 0.99 for all regions), whereas they were lower for atlas-AC, varying from 0.99 in the striatum to 0.88 in the posterior cortical regions. SUVR showed an overall bias of 2.9 and 0.5% for atlas-AC and ZTE-AC, respectively. Correlations with 68Ge-AC were higher for ZTE-AC, varying from 0.99 in the striatum to 0.96 in the limbic regions, compared to atlas-AC (0.99 striatum to 0.77 posterior cortex).ConclusionsAbsolute SUV values showed less variability for ZTE-AC than for atlas-AC when compared to 68Ge-AC, but bias was similar for both methods. This bias is largely caused by higher linear attenuation coefficients in atlas- and ZTE-AC image compared to 68Ge-images. For SUVR, bias was lower when using ZTE-AC than for atlas-AC. ZTE-AC shows to be a more robust technique than atlas-AC in terms of both intra- and inter-patient variability.

Technical Note: Virtual CT for reducing CT dose in targeted radionuclide therapy dosimetry.

Previously we have shown that using sequential CT images is superior to sequential SPECT for nonrigid registration in three-dimensional (3D) targeted radionuclide therapy (TRT) dosimetry. However, sequential CTs are often not available due to radiation concerns. In this paper, we propose a virtual CT (vCT) method for attenuation and scatter correction, image registration, and segmentation for improved dosimetric accuracy with single CT acquisition. We used a population of nine XCAT phantoms with different In-111 Zevalin biokinetics and anatomical variations for the simulations. An analytical projector was used to simulate sequential SPECT/CT acquisitions for a medium energy general purpose collimator at 1, 12, 24, 72, and 144 h postinjection, modeling attenuation, scatter, and geometric collimator-detector response. The corresponding sequential attenuation maps of the phantoms served as real CT (rCT) images. For vCT generation, we investigated three registration methods, that is, (a) SPECT to SPECT; (b) SPECT to CT, and (c) CT to SPECT, and the optimal time point for single CT acquisition. Difference images and average normalized mean square errors (NMSE) were calculated between different vCTs and their corresponding rCTs. Absorbed dose and dose-volume histograms (DVHs) for critical organs were computed for the rCT, optimized vCT, and conventional single CT (1CT) protocols, respectively, for dosimetric analyses. For vCT generation, SPECT to SPECT registration with a single CT acquired at the first time point shows the smallest difference and NMSE. For organ absorbed doses, the results of vCT were similar to those of rCT and were superior to 1CT, that is, -0.24 ± 1.56% vs -0.49 ± 1.76% vs -6.37 ± 5.63% for the liver, -1.05 ± 2.89% vs -0.69 ± 2.74% vs -4.87 ± 4.35% for kidneys, respectively. The results of DVHs also showed improvement for all organs using vCTs as compared to the conventional 1CT protocol. The optimized vCT method can effectively increase the TRT dosimetric results if there is only a single CT available in the sequential imaging protocol, reducing the substantial increase in radiation burden from repeated CT scans.

Intrascanner Reproducibility of an SPM-based Head MR-based Attenuation Correction Method.

Recently, an exhaustive examination of 11 state of the art MR-based attenuation correction (AC) concluded that there are currently a few methods showing similar results compared to the gold-standard, CT-based AC. While the study presented a thorough portfolio of metrics to quantify accuracy (bias) and quality, it lacked one of the most important metrics to quantify robustness that is critical for its clinical applicability: intrascanner reproducibility (repeatability). In this work, we provide for the first time a study of the repeatability of one of the outperforming brain MR-based AC methods: the SPM-based pseudo-CT approach. 22 subjects undergoing 3 18F-FDG PET/MRI visits within 2 months were retrospectively analyzed in this study. Pseudo-CT mu-maps were obtained from the coregistered MR images for all 3 visits and the PET data from visit 1 was reconstructed using all three mu-maps. Relative changes (RC), Intraclass correlation coefficient (ICC), Reproducibility coefficient (RDC95%) and Bland-Altman Limits of Agreement (LoA) were used to measure repeatability. Voxel-based and ROI-based results showed that absolute RC for the reconstructed PET images are within ~2%. The brain cortex and the cerebellum were the regions with the largest variability (~3%). The differences across visits were not statistically significant (p=0.90). In conclusion this study shows for the first time the repeatability of the SPM-based pseudo-CT approach for brain MR-AC. These results, in addition to the ease of implementation and the quality and robustness previously demonstrated, confer this SPM-based method an ideal candidate for routine brain PET/MRI research and clinical studies.

Developing an efficient phase-matched attenuation correction method for quiescent period PET in abdominal PET/MRI

Respiratory motion causes misalignments between positron emission tomography (PET) and magnetic resonance (MR)-derived attenuation maps (µ-maps) in addition to artifacts on both PET and MR images in simultaneous PET/MRI for organs such as liver that can experience motion of several centimeters. To address this problem, we developed an efficient MR-based attenuation correction (MRAC) method to generate phase-matched µ-maps for quiescent period PET (PETQ) in abdominal PET/MRI. MRAC data was acquired with CIRcular Cartesian UnderSampling (CIRCUS) sampling during 100 s in free-breathing as an accelerated data acquisition strategy for phase-matched MRAC (MRACPM-CIRCUS). For comparison, MRAC data with raster (Default) k-space sampling was also acquired during 100 s in free-breathing (MRACPM-Default), and used to evaluate MRACPM-CIRCUS as well as un-matched MRAC (MRACUM) that was un-gated. We purposefully oversampled the MRACPM data to ensure we had enough information to capture all respiratory phases to make this comparison as robust as possible. The proposed MRACPM-CIRCUS was evaluated in 17 patients with 68Ga-DOTA-TOC PET/MRI exams, suspected of having neuroendocrine tumors or liver metastases. Effects of CIRCUS sampling for accelerating a data acquisition were evaluated by simulating the data acquisition time retrospectively in increments of 5 s. Effects of MRACPM-CIRCUS on PETQ were evaluated using uptake differences in the liver lesions (n = 35), compared to PETQ with MRACPM-Default and MRACUM. A Wilcoxon signed-rank test was performed to compare lesion uptakes between the MRAC methods. MRACPM-CIRCUS showed higher image quality compared to MRACPM-Default for the same acquisition times, demonstrating that a data acquisition time of 30 s was reasonable to achieve phase-matched µ-maps. Lesion update differences between MRACPM-CIRCUS (30 s) versus MRACPM-Default (reference, 100 s) were 0.1% ± 1.4% (range of −2.7% to 3.2%) and not significant (P > .05); while, the differences between MRACUM versus MRACPM-Default were 0.6% ± 11.4% with a large variation (range of −37% to 20%) and significant (P < .05). In conclusion, we demonstrated that a data acquisition of 30 s achieved phase-matched µ-maps when using specialized CIRCUS data sampling and phase-matched µ-maps improved PETQ quantification significantly.

Synthesis of Patient-Specific Transmission Data for PET Attenuation Correction for PET/MRI Neuroimaging Using a Convolutional Neural Network.

Attenuation correction is a notable challenge associated with simultaneous PET/MRI, particularly in neuroimaging, where sharp boundaries between air and bone volumes exist. This challenge leads to concerns about the visual and, more specifically, quantitative accuracy of PET reconstructions for data obtained with PET/MRI. Recently developed techniques can synthesize attenuation maps using only MRI data and are likely adequate for clinical use; however, little work has been conducted to assess their suitability for the dynamic PET studies frequently used in research to derive physiologic information such as the binding potential of neuroreceptors in a region. At the same time, existing PET/MRI attenuation correction methods are predicated on synthesizing CT data, which is not ideal, as CT data are acquired with much lower-energy photons than PET data and thus do not optimally reflect the PET attenuation map. Methods: We trained a convolutional neural network to generate patient-specific transmission data from T1-weighted MRI. Using the trained network, we generated transmission data for a testing set comprising 11 subjects scanned with 11C-labeled N-[2-]4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide) (11C-WAY-100635) and 10 subjects scanned with 11C-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)benzonitrile (11C-DASB). We assessed both static and dynamic reconstructions. For dynamic PET data, we report differences in both the nondisplaceable and the free binding potential for 11C-WAY-100635 and distribution volume for 11C-DASB. Results: The mean bias for generated transmission data was -1.06% ± 0.81%. Global biases in static PET uptake were -0.49% ± 1.7%, and -1.52% ± 0.73% for 11C-WAY-100635 and 11C-DASB, respectively. Conclusion: Our neural network approach is capable of synthesizing patient-specific transmission data with sufficient accuracy for both static and dynamic PET studies.

Probing star formation and ISM properties using galaxy disk inclination

We evaluate dust-corrected far-ultraviolet (FUV) star formation rates (SFRs) for samples of star-forming galaxies at z ~ 0 and z ~ 0.7 and find significant differences between values obtained through corrections based on UV colour, from a hybrid mid-infrared (MIR) plus FUV relation, and from a radiative transfer based attenuation correction method. The performances of the attenuation correction methods are assessed by their ability to remove the dependency of the corrected SFR on inclination, as well as returning, on average, the expected population mean SFR. We find that combining MIR (rest-frame ~ 13 μm) and FUV luminosities gives the most inclination-independent SFRs and reduces the intrinsic SFR scatter of the methods we tested. However, applying the radiative transfer based method also gives corrections to the FUV SFR that are inclination independent and in agreement with the expected SFRs at both z ~ 0 and z ~ 0.7. SFR corrections based on the UV-slope perform worse than the other two methods we tested. For our local sample, the UV-slope method works on average, but does not remove inclination biases. At z ~ 0.7, we find that the UV-slope correction we used locally flattens the inclination dependence compared to the raw FUV measurements, but was not sufficient to correct for the large attenuation observed at z ~ 0.7.

Improving PET/MR brain quantitation with template-enhanced ZTE

PurposeThe impact of MR-based attenuation correction on PET quantitation accuracy is an ongoing cause of concern for advanced brain research with PET/MR. The purpose of this study was to evaluate a new, template-enhanced zero-echo-time attenuation correction method for PET/MR scanners. Methods30 subjects underwent a clinically-indicated 18F-FDG-PET/CT, followed by PET/MR on a GE SIGNA PET/MR. For each patient, a 42-s zero echo time (ZTE) sequence was used to generate two attenuation maps: one with the standard ZTE segmentation-based method; and another with a modification of the method, wherein pre-registered anatomical templates and CT data were used to enhance the segmentation. CT data, was used as gold standard. Reconstructed PET images were qualified visually and quantified in 68 volumes-of-interest using a standardized brain atlas. ResultsAttenuation maps were successfully generated in all cases, without manual intervention or parameter tuning. One patient was excluded from the quantitative analysis due to the presence of multiple brain metastases. The PET bias with template-enhanced ZTE attenuation correction was measured to be −0.9% ± 0.9%, compared with −1.4% ± 1.1% with regular ZTE attenuation correction. In terms of absolute bias, the new method yielded 1.1% ± 0.7%, compared with 1.6% ± 0.9% with regular ZTE. Statistically significant bias reduction was obtained in the frontal region (from −2.0% to −1.0%), temporal (from −1.2% to −0.2%), parietal (from −1.9% to −1.1%), occipital (from −2.0% to −1.1%) and insula (from −1.4% to −1.1%). ConclusionThese results indicate that the co-registration of pre-recorded anatomical templates to ZTE data is feasible in clinical practice and can be effectively used to improve the performance of segmentation-based attenuation correction.